System Transmission

Top Signal

100#1 JOB

Activity

2173Ripe

+929 today

System

Livenow

Terminal Asset View

stockNASDAQ

IOVA

$3.96-2.70%

Iovance Biotherapeutics Inc

Overripe

Market value

24H Total Traded

Total supply

52-Week Range

Ripeness Index

7Overripe

Live Analysis Active

Company Mission

Iovance Biotherapeutics creates personalized cancer treatments by taking a patient's own immune cells and modifying them to fight cancer. Doctors use these treatments for patients with certain types of cancer when other options haven't worked. The company makes money through clinical trials and hopes to earn revenue from selling approved treatments to hospitals and healthcare providers.

IOV

Industry Context

The biotechnology industry focuses on developing new medical treatments using living organisms. Companies in this space often spend years in research and clinical trials before earning revenue from approved drugs. Regulatory approvals and scientific breakthroughs can significantly impact stock prices in this volatile sector.

Scoring Terminal

Intelligence Pipeline Active

Algorithm Verified

Asset Diagnostics

ProtocolV2.1_TACTICAL

Technical Matrix

Scanning

38Matrix

Market Momentum

53.3— Holding Steady

Trend Strength

50— Active Setup

Momentum Engine

Ready

Velocity Score

StaticOptimal FlowMax Vel

Trading Activity

0.9x— Normal Volume

Today's Change

-2.70%— Live Performance

Social Frequency

Listening

Social Freq

0.0x

Normal Vol

X/Twitter Activity

0.0x— Streaming

Reddit Buzz

0.0x— Synced

System Observation

ANALYSIS:Monitoring pattern stability. Currently scanning for high-confidence technical signals.

Lat14ms

BufOK

Positive Catalysts

No active score modifiers detected

Risk Flags

52W Threshold-1

Price is extended significantly above 52-week highs.

Banana Farmer tracks 100's of signals to synthesize this proprietary score.

0Velocity

Awaiting Data

Social Intelligence Pulse.

Our engine is currently indexing IOVA across global social channels to detect early sentiment shifts and technical alignment.

XMonitoring

RedditMonitoring

WebMonitoring

Social GrowthPending

Signal CoverageInitializing

Signal Catalysts

Intelligence Narrative Connected

Updated 08:16 PM UTC

As-of 03-14-2026 20:00 UTC

Develops cancer treatments using patients' own immune cells and makes money by selling these therapies to hospitals and clinics.

Price is compressing on the weekly chart near recent lows, suggesting potential volatility expansion soon as the range tightens showing showing.

Biotech sector faces regulatory uncertainty, which could impact approval timelines for innovative cell therapies like this company's.

Educational only. Not investment advice.

Precision Intelligence Model

Live Terminal Stream

Loading chart...